Company Analysis

Marker Therapeutics, Inc. (MRKR)

Nasdaq: MRKR · Pharmaceutical Preparations · Houston, TX · filing with the SEC since 1999
Grade4.5
◀ Past 5.0● Present 4.4▶ Future 4.2
1 est.

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedMar 18, 2026Mar 31, 2025Mar 26, 2024Mar 22, 2023Mar 17, 2022Mar 9, 2021Mar 12, 2020Mar 15, 2019Mar 23, 2018Mar 14, 2017
Revenue3,546,6696,591,0803,311,1333,513,544r1,241,710466,785213,194205,994183,064·
Research and development11,799,15413,467,84510,416,78911,968,428r27,794,87918,880,75112,764,8047,952,8705,250,9853,800,035
General and administrative4,184,8064,241,6077,475,72211,336,120r12,924,82610,471,8469,977,19624,379,8716,412,1214,692,234
Total operating expenses16,437,09517,709,45217,892,51123,304,548r40,719,70529,352,59722,742,000148,377,62711,663,1068,492,269
Total costs and expenses4,568,4855,853,179r1,620,0001,508,000······
Operating income-12,890,426-11,118,372-14,581,378-19,791,004r-39,477,995-28,885,812-22,528,806-148,171,633-11,480,042r-8,492,269
Interest and investment income594,206437,010539,158248,0635,700148,7421,082,842253,7230·
Income before income taxes-12,178,776-10,681,362-14,042,220-19,775,915······
Income tax expense-15,15649,9533,675····000
Income from continuing operations·-10,731,315-14,045,895-19,775,915······
Income from discontinued operations··5,809,081-10,154,779······
Net income including non-controlling interests-12,163,620-10,731,315-8,236,814-29,930,694-41,878,871-28,706,070-21,427,964-147,957,910··
Net income-12,163,620-10,731,315-8,236,814-29,930,694-41,878,871-28,706,070-21,427,964-147,957,910-10,982,177-2,455,381
Earnings per share, basic-0.79-1.19-0.94-3.58-5.47r-6.10b··-11.60b-3.60b
Earnings per share, diluted-0.79-1.19-0.94-3.58-5.47r-6.10b··-11.60b-7.20b
Earnings per share, basic and diluted·····-6.10b-4.70b-77.50b-11.60b·
Weighted average shares, basic15,310,3088,980,2078,809,3828,351,0037,650,567r4,703,986b4,558,773b1,909,193b945,348b688,990b
Weighted average shares, diluted15,310,3088,980,2078,809,3828,351,0037,650,567r4,703,986b··945,348b742,100b
Weighted average shares, basic and diluted·····4,703,986b4,558,773b1,909,193b945,348b·
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-10 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:Revenues
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Total costs and expenses every operating cost, the cost of revenue includedus-gaap:OperatingCostsAndExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Income from continuing operations profit from the businesses it keepsus-gaap:IncomeLossFromContinuingOperations
Income from discontinued operations profit or loss from businesses it sold or closedus-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton MRKR · research, not advice